Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06201234
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2023-12-07
Brief Title:
Evaluating the Addition of Elacestrant Oral SERD to Olaparib PARP-inhibitor in Patients With AdvancedMetastatic HRHER2- Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-07
First Submit QC Date:
December 29 2023
Study First Post Date:
2024-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-01-11
Last Update Post Date Type:
ACTUAL